abstract |
This invention relates to potent selective agonists of the EP 4 subtypenof prostaglandin E2 receptors of formula (I), their use or a formulation thereofnin the treatment of glaucoma and other conditions which are related to elevatednintraocular pressure in the eye of the patient. |